Ninety One UK Ltd holds a diversified book of 237 stocks worth $43.1B as of Q1 2026 (disclosed Apr 24, 2026, a ~45-day 13F lag). This quarter they opened AstraZeneca PLC and trimmed Alphabet Inc-CL A. Their largest long position is Alphabet Inc-CL A at 6% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1418329/holdings"
Use Arkolith to show Ninety One UK Ltd's latest holdings, largest changes, and filing provenance.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Alphabet Inc Common Stock | $2.4B | 8.27M | 5.5% | ▼−7.9% Reduced · −706K sh | |
| 2 | Microsoft Corp Common Stock | $2.0B | 5.40M | 4.6% | ▼−18% Reduced · −1.2M sh | |
| 3 | Nvidia Corp Common Stock | $2.0B | 11.29M | 4.6% | ▼−9.8% Reduced · −1.2M sh | |
| 4 | Visa Inc Common Stock | $1.8B | 6.11M | 4.3% | ▼~0% Reduced · −3K sh | |
| 5 | Johnson & Johnson Common Stock | $1.6B | 6.64M | 3.8% | ▼−2.5% Reduced · −168K sh | |
| 6 | Apple Inc Common Stock | $1.3B | 5.06M | 3.0% | ▲+69% Added · +2.1M sh | |
| 7 | Philip Morris International Inc Common Stock | $1.2B | 7.16M | 2.7% | ▲+0.1% Added · +10K sh | |
| 8 | Booking Holdings Inc Common Stock | $1.1B | 253.4K | 2.5% | ▲+22% Added · +45K sh | |
| 9 | Edwards Lifesciences Corp Common Stock | $992.7M | 12.40M | 2.3% | ▲+60% Added · +4.7M sh | |
| 10 | Autodesk Inc Common Stock | $963.7M | 4.03M | 2.2% | ▼−13% Reduced · −616K sh | |
| 11 | Amazon.com Inc Common Stock | $927.7M | 4.45M | 2.2% | ▲+0.4% Added · +19K sh | |
| 12 | Broadcom Inc Common Stock | $887.7M | 2.87M | 2.1% | ▼−20% Reduced · −721K sh | |
| 13 | Electronic Arts Inc Common Stock | $851.3M | 4.18M | 2.0% | ▲+0.5% Added · +19K sh | |
| 14 | Intuit Inc Common Stock | $813.2M | 1.88M | 1.9% | ▲+35% Added · +488K sh | |
| 15 | TKO Group Holdings Inc Common Stock | $729.8M | 3.62M | 1.7% | ▼−28% Reduced · −1.4M sh | |
| 16 | NetEase Inc ADR | $703.7M | 6.29M | 1.6% | ▼−0.1% Reduced · −9K sh | |
| 17 | Marsh & McLennan Cos Inc Common Stock | $698.9M | 4.03M | 1.6% | ▲+14% Added · +487K sh | |
| 18 | Exxon Mobil Corp Common Stock | $698.2M | 4.12M | 1.6% | ▲+48% Added · +1.3M sh | |
| 19 | JPMorgan Chase & Co Common Stock | $678.2M | 2.31M | 1.6% | ▲+14% Added · +284K sh | |
| 20 | Motorola Solutions Inc Common Stock | $584.0M | 1.35M | 1.4% | ▲+0.5% Added · +7K sh | |
| 21 | Monster Beverage Corp Common Stock | $540.2M | 7.46M | 1.3% | ▼−13% Reduced · −1.1M sh | |
| 22 | Mastercard Inc Common Stock | $533.5M | 1.07M | 1.2% | ▼−14% Reduced · −169K sh | |
| 23 | Taiwan Semiconductor Manufacturing Co Ltd ADR | $533.0M | 1.58M | 1.2% | ▼−22% Reduced · −436K sh | |
| 24 | VeriSign Inc Common Stock | $515.9M | 2.08M | 1.2% | ▲+0.3% Added · +7K sh | |
| 25 | Barrick Mining Corp Common Stock | $486.3M | 11.92M | 1.1% | ▼−11% Reduced · −1.4M sh | |
| 26 | Eli Lilly & Co Common Stock | $482.2M | 524.2K | 1.1% | ▼−3.1% Reduced · −17K sh | |
| 27 | Automatic Data Processing Inc Common Stock | $480.3M | 2.36M | 1.1% | ▼−0.5% Reduced · −11K sh | |
| 28 | Boston Scientific Corp Common Stock | $458.6M | 7.31M | 1.1% | ▲+34% Added · +1.9M sh | |
| 29 | Chevron Corp Common Stock | $416.8M | 2.01M | 1.0% | ▲+382% Added · +1.6M sh | |
| 30 | S&P Global Inc Common Stock | $416.8M | 979.9K | 1.0% | ▲+6.4% Added · +59K sh | |
| 31 | Jacobs Solutions Inc Common Stock | $414.3M | 3.26M | 1.0% | ▲+3.1% Added · +99K sh | |
| 32 | Citizens Financial Group Inc Common Stock | $405.9M | 6.77M | 0.9% | ▲+2.9% Added · +194K sh | |
| 33 | AstraZeneca PLC Common Stock | $396.5M | 2.05M | 0.9% | ▲New New position | |
| 34 | AerCap Holdings NV Common Stock | $385.5M | 2.81M | 0.9% | ▲+0.2% Added · +6K sh | |
| 35 | Align Technology Inc Common Stock | $382.0M | 2.23M | 0.9% | ▲~0% Added · +911 sh | |
| 36 | Ferrari NV Common Stock | $367.7M | 1.10M | 0.9% | ▲+22% Added · +199K sh | |
| 37 | Moody's Corp Common Stock | $366.6M | 840.3K | 0.9% | ▲+0.5% Added · +4K sh | |
| 38 | Check Point Software Technologies Ltd Common Stock | $366.1M | 2.56M | 0.8% | ▲+0.5% Added · +13K sh | |
| 39 | TD Synnex Corp Common Stock | $353.3M | 2.09M | 0.8% | ▼−6.0% Reduced · −135K sh | |
| 40 | CRH PLC Common Stock | $349.1M | 3.32M | 0.8% | ▼−3.6% Reduced · −125K sh | |
| 41 | Trane Technologies PLC Common Stock | $342.2M | 821.0K | 0.8% | ▲+22% Added · +147K sh | |
| 42 | General Motors Co Common Stock | $337.4M | 4.53M | 0.8% | ▼−8.4% Reduced · −414K sh | |
| 43 | UBS Group AG Common Stock | $332.3M | 8.69M | 0.8% | ▼−1.6% Reduced · −142K sh | |
| 44 | Abbott Laboratories Common Stock | $319.3M | 3.11M | 0.7% | ▲+16% Added · +421K sh | |
| 45 | Thermo Fisher Scientific Inc Common Stock | $313.2M | 637.3K | 0.7% | ▼−29% Reduced · −255K sh | |
| 46 | Meta Platforms Inc Common Stock | $302.6M | 528.8K | 0.7% | ▲+32% Added · +128K sh | |
| 47 | Goldman Sachs Group Inc Common Stock | $298.4M | 352.8K | 0.7% | ▼−28% Reduced · −135K sh | |
| 48 | NextEra Energy Inc Common Stock | $281.8M | 3.03M | 0.7% | ▲+59% Added · +1.1M sh | |
| 49 | Freeport-McMoRan Inc Common Stock | $269.5M | 4.58M | 0.6% | ▼−1.3% Reduced · −60K sh | |
| 50 | FactSet Research Systems Inc Common Stock | $259.3M | 1.19M | 0.6% | ▲~0% Added · +20 sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | Apr 24, 2026 | 237 | $43.1B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 27, 2026 | 225 | $46.6B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 | 212 | $46.3B | 13F-HR/A |
| Q2 2025 | Jun 30, 2025 | Jul 18, 2025 | 202 | $42.6B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 30, 2025 | 193 | $35.9B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 27, 2025 | 191 | $37.4B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 | 194 | $37.5B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 22, 2024 | 187 | $36.2B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Apr 25, 2024 | 185 | $35.6B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Jan 31, 2024 | 178 | $33.6B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Oct 10, 2023 | 177 | $31.6B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Jul 19, 2023 | 183 | $34.3B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | Apr 28, 2023 | 180 | $32.1B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 7, 2023 | 187 | $31.2B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 190 | $30.3B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 190 | $33.6B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 26, 2022 | 196 | $39.3B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 11, 2022 | 208 | $42.1B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 2, 2021 | 208 | $39.2B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 | 209 | $38.6B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 7, 2021 | 215 | $35.2B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 5, 2021 | 219 | $32.5B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 12, 2020 | 223 | $27.7B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.